#EXP00158

General

Accession EXP00158
Activity Preformed biofilm
Date 2013-11-26
Administration In solution
Model in vitro
Organism Staphylococcus aureus
Status Validated
Notes Sa7 clinical isolate

Peptide

SMAP-29

RGLRRLGRKIAHGVKKYGPTVLRIIRIA

Experimental activity

Method Concentration Notes
Total countable CFUs 1.251 uM No notes
Total countable CFUs 6.256 uM No notes

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814